{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,22]],"date-time":"2026-07-22T02:35:17Z","timestamp":1784687717484,"version":"3.55.0"},"reference-count":282,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2020,2,1]],"date-time":"2020-02-01T00:00:00Z","timestamp":1580515200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,2,1]],"date-time":"2020-02-01T00:00:00Z","timestamp":1580515200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Pharmacology & Therapeutics"],"published-print":{"date-parts":[[2020,2]]},"DOI":"10.1016\/j.pharmthera.2019.107428","type":"journal-article","created":{"date-parts":[[2019,10,15]],"date-time":"2019-10-15T19:43:07Z","timestamp":1571168587000},"page":"107428","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":32,"special_numbering":"C","title":["Use of glucocorticoids in the critical care setting: Science and clinical evidence"],"prefix":"10.1016","volume":"206","author":[{"given":"Edward D.","family":"Chan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael M.","family":"Chan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mallory M.","family":"Chan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul E.","family":"Marik","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.pharmthera.2019.107428_bib0005","doi-asserted-by":"crossref","first-page":"307","DOI":"10.2165\/00151829-200403050-00005","article-title":"Pharmacologic treatments for acute respiratory distress syndrome and acute lung injury: Systematic review and meta-analysis","volume":"3","author":"Adhikari","year":"2004","journal-title":"Treatments in Respiratory Medicine"},{"key":"10.1016\/j.pharmthera.2019.107428_bib0010","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1111\/j.1440-1843.2007.01060.x","article-title":"Do glucocorticoids decrease mortality in acute respiratory distress syndrome? A meta-analysis","volume":"12","author":"Agarwal","year":"2007","journal-title":"Respirology"},{"key":"10.1016\/j.pharmthera.2019.107428_bib0015","doi-asserted-by":"crossref","first-page":"1139","DOI":"10.1507\/endocrj.EJ18-0135","article-title":"Glucocorticoid resistance syndrome caused by a novel NR3C1 point mutation","volume":"65","author":"Al Argan","year":"2018","journal-title":"Endocrine Journal"},{"key":"10.1016\/j.pharmthera.2019.107428_bib0020","doi-asserted-by":"crossref","first-page":"133","DOI":"10.4103\/1817-1737.65040","article-title":"Genomic and non-genomic actions of glucocorticoids in asthma","volume":"5","author":"Alangari","year":"2010","journal-title":"Annals of Thoracic Medicine"},{"key":"10.1016\/j.pharmthera.2019.107428_bib0025","doi-asserted-by":"crossref","DOI":"10.1097\/CCM.0000000000003889","article-title":"Why my steroid trials in septic shock were \"positive\"?","author":"Annane","year":"2019","journal-title":"Critical Care Medicine"},{"key":"10.1016\/j.pharmthera.2019.107428_bib0030","doi-asserted-by":"crossref","first-page":"2362","DOI":"10.1001\/jama.2009.815","article-title":"Corticosteroids in the treatment of severe sepsis and septic shock in adults: A systematic review","volume":"301","author":"Annane","year":"2009","journal-title":"JAMA"},{"key":"10.1016\/j.pharmthera.2019.107428_bib0035","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1136\/bmj.38181.482222.55","article-title":"Corticosteroids for severe sepsis and septic shock: A systematic review and meta-analysis","volume":"329","author":"Annane","year":"2004","journal-title":"BMJ"},{"key":"10.1016\/j.pharmthera.2019.107428_bib0040","first-page":"CD002243","article-title":"Corticosteroids for treating sepsis","volume":"12","author":"Annane","year":"2015","journal-title":"The Cochrane Database of Systematic Reviews"},{"key":"10.1016\/j.pharmthera.2019.107428_bib0045","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1186\/cc6940","article-title":"Corticosteroids for community-acquired pneumonia: Time to act!","volume":"12","author":"Annane","year":"2008","journal-title":"Critical Care"},{"key":"10.1016\/j.pharmthera.2019.107428_bib0050","doi-asserted-by":"crossref","first-page":"2078","DOI":"10.1097\/CCM.0000000000002737","article-title":"Guidelines for the diagnosis and management of critical illness-related corticosteroid insufficiency (CIRCI) in critically ill patients (Part I): Society of critical care medicine (SCCM) and european society of intensive care medicine (ESICM) 2017","volume":"45","author":"Annane","year":"2017","journal-title":"Critical Care Medicine"},{"key":"10.1016\/j.pharmthera.2019.107428_bib0055","doi-asserted-by":"crossref","first-page":"809","DOI":"10.1056\/NEJMoa1705716","article-title":"CRICS-TRIGGERSEP Network. Hydrocortisone plus fludrocortisone for adults with septic shock","volume":"378","author":"Annane","year":"2018","journal-title":"The New England Journal of Medicine"},{"key":"10.1016\/j.pharmthera.2019.107428_bib0060","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1097\/01.CCM.0000194723.78632.62","article-title":"Effect of low doses of corticosteroids in septic shock patients with or without early acute respiratory distress syndrome","volume":"34","author":"Annane","year":"2006","journal-title":"Critical Care Medicine"},{"key":"10.1016\/j.pharmthera.2019.107428_bib0065","doi-asserted-by":"crossref","first-page":"862","DOI":"10.1001\/jama.288.7.862","article-title":"Effect of treatment with low doses of hydrocortisone and fludrocortisone on mortality in patients with septic shock","volume":"288","author":"Annane","year":"2002","journal-title":"JAMA"},{"key":"10.1016\/j.pharmthera.2019.107428_bib0070","doi-asserted-by":"crossref","first-page":"980","DOI":"10.1164\/rccm.201807-1419OC","article-title":"Transcriptomic Signatures in Sepsis and a Differential Response to Steroids. From the VANISH Randomized Trial","volume":"199","author":"Antcliffe","year":"2019","journal-title":"American Journal of Respiratory and Critical Care Medicine"},{"key":"10.1016\/j.pharmthera.2019.107428_bib0075","doi-asserted-by":"crossref","first-page":"1673","DOI":"10.1007\/s00134-012-2619-8","article-title":"Etomidate increases susceptibility to pneumonia in trauma patients","volume":"38","author":"Asehnoune","year":"2012","journal-title":"Intensive Care Medicine"},{"key":"10.1016\/j.pharmthera.2019.107428_bib0080","first-page":"272","article-title":"Protective effects of hydrocortisone, vitamin C and E alone or in combination against renal ischemia-reperfusion injury in rat","volume":"10","author":"Azari","year":"2015","journal-title":"Iranian Journal of Pathology"},{"key":"10.1016\/j.pharmthera.2019.107428_bib0085","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1164\/rccm.201810-1945ED","article-title":"Critical Care Management of Chimeric Antigen Receptor T Cell-related Toxicity. Be Aware and Prepared","volume":"200","author":"Azoulay","year":"2019","journal-title":"American Journal of Respiratory and Critical Care Medicine"},{"key":"10.1016\/j.pharmthera.2019.107428_bib0090","first-page":"745","article-title":"Mapracorat, a selective glucocorticoid receptor agonist, causes apoptosis of eosinophils infiltrating the conjunctiva in late-phase experimental ocular allergy","volume":"8","author":"Baiula","year":"2014","journal-title":"Drug Design, Development and Therapy"},{"key":"10.1016\/j.pharmthera.2019.107428_bib0095","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1200\/JCO.1987.5.2.202","article-title":"Differences in cerebrospinal fluid penetration of corticosteroids: Possible relationship to the prevention of meningeal leukemia","volume":"5","author":"Balis","year":"1987","journal-title":"Journal of Clinical Oncology"},{"key":"10.1016\/j.pharmthera.2019.107428_bib0100","doi-asserted-by":"crossref","first-page":"954","DOI":"10.1016\/j.chest.2017.07.014","article-title":"Hydrocortisone and ascorbic acid synergistically prevent and repair lipopolysaccharide-induced pulmonary endothelial barrier dysfunction","volume":"152","author":"Barabutis","year":"2017","journal-title":"Chest"},{"key":"10.1016\/j.pharmthera.2019.107428_bib0105","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1016\/j.jsbmb.2010.02.018","article-title":"Mechanisms and resistance in glucocorticoid control of inflammation","volume":"120","author":"Barnes","year":"2010","journal-title":"The Journal of Steroid Biochemistry and Molecular Biology"},{"key":"10.1016\/j.pharmthera.2019.107428_bib0110","doi-asserted-by":"crossref","first-page":"R102","DOI":"10.1186\/cc9044","article-title":"Global utilization of low-dose corticosteroids in severe sepsis and septic shock: A report from the PROGRESS registry","volume":"14","author":"Beale","year":"2010","journal-title":"Crit Care"},{"key":"10.1016\/j.pharmthera.2019.107428_bib0115","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1186\/s12883-017-0994-z","article-title":"Pharmacological targeting of secondary brain damage following ischemic or hemorrhagic stroke, traumatic brain injury, and bacterial meningitis - a systematic review and meta-analysis","volume":"17","author":"Beez","year":"2017","journal-title":"BMC Neurology"},{"key":"10.1016\/j.pharmthera.2019.107428_bib0120","doi-asserted-by":"crossref","first-page":"788","DOI":"10.1001\/jama.2016.0291","article-title":"LUNG SAFE investigators; ESICM trials group. epidemiology, patterns of care, and mortality for patients with acute respiratory distress syndrome in intensive care units in 50 countries","volume":"315","author":"Bellani","year":"2016","journal-title":"JAMA"},{"key":"10.1016\/j.pharmthera.2019.107428_bib0125","doi-asserted-by":"crossref","first-page":"1970","DOI":"10.1007\/s00134-016-4338-z","article-title":"Plasma cytokine levels predict response to corticosteroids in septic shock","volume":"42","author":"Bentzer","year":"2016","journal-title":"Intensive Care Medicine"},{"key":"10.1016\/j.pharmthera.2019.107428_bib0130","doi-asserted-by":"crossref","first-page":"574","DOI":"10.1016\/j.jinf.2013.07.028","article-title":"Expression of the glucocorticoid receptor is decreased in experimental Staphylococcus aureus sepsis","volume":"67","author":"Bergquist","year":"2013","journal-title":"The Journal of Infection"},{"key":"10.1016\/j.pharmthera.2019.107428_bib0135","doi-asserted-by":"crossref","first-page":"1565","DOI":"10.1056\/NEJM198712173172504","article-title":"High-dose corticosteroids in patients with the adult respiratory distress syndrome","volume":"317","author":"Bernard","year":"1987","journal-title":"The New England Journal of Medicine"},{"key":"10.1016\/j.pharmthera.2019.107428_bib0140","doi-asserted-by":"crossref","first-page":"4313","DOI":"10.1182\/blood-2006-10-048215","article-title":"Macrophage glucocorticoid receptors regulate toll-like receptor 4-mediated inflammatory responses by selective inhibition of p38 MAP kinase","volume":"109","author":"Bhattacharyya","year":"2007","journal-title":"Blood"},{"key":"10.1016\/j.pharmthera.2019.107428_bib0145","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0165942","article-title":"Efficacy and safety of adjunctive corticosteroids therapy for severe community-acquired pneumonia in adults: An updated systematic review and meta-analysis","volume":"11","author":"Bi","year":"2016","journal-title":"PloS One"},{"key":"10.1016\/j.pharmthera.2019.107428_bib0150","series-title":"UpToDate","article-title":"Overview of the treatment of myasthenia gravis","author":"Bird","year":"2019"},{"key":"10.1016\/j.pharmthera.2019.107428_bib0155","series-title":"UpToDate","article-title":"Myasthenic crisis","author":"Bird","year":"2019"},{"key":"10.1016\/j.pharmthera.2019.107428_bib0160","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1016\/j.cmi.2016.09.002","article-title":"Corticosteroids in treating community-acquired pneumonia: has the time really come?","volume":"23","author":"Blot","year":"2017","journal-title":"Clinical Microbiology and Infection"},{"key":"10.1016\/j.pharmthera.2019.107428_bib0165","doi-asserted-by":"crossref","first-page":"1511","DOI":"10.1016\/S0140-6736(14)62447-8","article-title":"Adjunct prednisone therapy for patients with community-acquired pneumonia: A multicentre, double-blind, randomised, placebo-controlled trial","volume":"385","author":"Blum","year":"2015","journal-title":"Lancet"},{"key":"10.1016\/j.pharmthera.2019.107428_bib0170","article-title":"Cosyntropin testing does not predict response to glucocorticoids in community-acquired pneumonia in a randomized controlled trial","author":"Blum","year":"2018","journal-title":"Clinical Endocrinology (Oxford)"},{"key":"10.1016\/j.pharmthera.2019.107428_bib0175","doi-asserted-by":"crossref","first-page":"1032","DOI":"10.1378\/chest.92.6.1032","article-title":"Early methylprednisolone treatment for septic syndrome and the adult respiratory distress syndrome","volume":"92","author":"Bone","year":"1987","journal-title":"Chest"},{"key":"10.1016\/j.pharmthera.2019.107428_bib0180","doi-asserted-by":"crossref","first-page":"562","DOI":"10.1016\/j.tube.2015.05.011","article-title":"Effect of cortisol and\/or DHEA on THP1-derived macrophages infected with Mycobacterium tuberculosis","volume":"95","author":"Bongiovanni","year":"2015","journal-title":"Tuberculosis (Edinburgh, Scotland)"},{"key":"10.1016\/j.pharmthera.2019.107428_bib0185","doi-asserted-by":"crossref","first-page":"1451","DOI":"10.1056\/NEJM199011223232104","article-title":"A controlled trial of early adjunctive treatment with corticosteroids for Pneumocystis carinii pneumonia in the acquired immunodeficiency syndrome. California Collaborative Treatment Group","volume":"323","author":"Bozzette","year":"1990","journal-title":"The New England Journal of Medicine"},{"key":"10.1016\/j.pharmthera.2019.107428_bib0190","doi-asserted-by":"crossref","first-page":"23","DOI":"10.3171\/jns.1992.76.1.0023","article-title":"Methylprednisolone or naloxone treatment after acute spinal cord injury: 1-year follow-up data. Results of the second National Acute Spinal Cord Injury Study","volume":"76","author":"Bracken","year":"1992","journal-title":"Journal of Neurosurgery"},{"key":"10.1016\/j.pharmthera.2019.107428_bib0195","doi-asserted-by":"crossref","first-page":"1597","DOI":"10.1001\/jama.1997.03540440031029","volume":"277","author":"Bracken","year":"1997","journal-title":"JAMA"},{"key":"10.1016\/j.pharmthera.2019.107428_bib0200","doi-asserted-by":"crossref","first-page":"699","DOI":"10.3171\/jns.1998.89.5.0699","article-title":"Methylprednisolone or tirilazad mesylate administration after acute spinal cord injury: 1-year follow up. Results of the third National Acute Spinal Cord Injury randomized controlled trial","volume":"89","author":"Bracken","year":"1998","journal-title":"Journal of Neurosurgery"},{"key":"10.1016\/j.pharmthera.2019.107428_bib0205","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1186\/1471-2334-5-101","article-title":"Adjunctive corticosteroids for Pneumocystis jiroveci pneumonia in patients with HIV infection: A meta-analysis of randomised controlled trials","volume":"5","author":"Briel","year":"2005","journal-title":"BMC Infectious Diseases"},{"key":"10.1016\/j.pharmthera.2019.107428_bib0210","first-page":"CD006150","article-title":"Adjunctive corticosteroids for Pneumocystis jiroveci pneumonia in patients with HIV-infection","volume":"19","author":"Briel","year":"2006","journal-title":"The Cochrane Database of Systematic Reviews"},{"key":"10.1016\/j.pharmthera.2019.107428_bib0215","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1093\/cid\/cix801","article-title":"Ovidius study group; capisce study group; STEP study group. Corticosteroids in patients hospitalized with community-acquired pneumonia: Systematic review and individual patient data metaanalysis","volume":"66","author":"Briel","year":"2018","journal-title":"Clinical Infectious Diseases"},{"key":"10.1016\/j.pharmthera.2019.107428_bib0220","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1093\/intimm\/dxr048","article-title":"Corticosteroids shift the Toll-like receptor response pattern of primary-isolated murine liver cells from an inflammatory to an anti-inflammatory state","volume":"23","author":"Broering","year":"2011","journal-title":"International Immunology"},{"key":"10.1016\/j.pharmthera.2019.107428_bib0225","first-page":"CD010225","article-title":"Single induction dose of etomidate versus other induction agents for endotracheal intubation in critically ill patients","volume":"1","author":"Bruder","year":"2015","journal-title":"The Cochrane Database of Systematic Reviews"},{"key":"10.1016\/j.pharmthera.2019.107428_bib0230","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1186\/cc13903","article-title":"Epinephrine, vasopression and steroids for in-hospital cardiac arrest: the right cocktail therapy?","volume":"18","author":"Buddineni","year":"2014","journal-title":"Critical Care"},{"key":"10.1016\/j.pharmthera.2019.107428_bib0235","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/j.tem.2012.11.005","article-title":"The five Rs of glucocorticoid action during inflammation: Ready, reinforce, repress, resolve, and restore","volume":"24","author":"Busillo","year":"2013","journal-title":"Trends in Endocrinology and Metabolism: TEM"},{"key":"10.1016\/j.pharmthera.2019.107428_bib0240","doi-asserted-by":"crossref","first-page":"718","DOI":"10.1136\/ard.61.8.718","article-title":"Standardised nomenclature for glucocorticoid dosages and glucocorticoid treatment regimens: Current questions and tentative answers in rheumatology","volume":"61","author":"Buttgereit","year":"2002","journal-title":"Annals of the Rheumatic Diseases"},{"key":"10.1016\/j.pharmthera.2019.107428_bib0245","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1038\/nri.2017.1","article-title":"Immune regulation by glucocorticoids","volume":"17","author":"Cain","year":"2017","journal-title":"Nature Reviews Immunology"},{"key":"10.1016\/j.pharmthera.2019.107428_bib0250","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1513\/AnnalsATS.201806-419OC","article-title":"SIXTUS study group. Corticosteroid use and incident myocardial infarction in adults hospitalized for community-acquired pneumonia","volume":"16","author":"Cangemi","year":"2019","journal-title":"Annals of the American Thoracic Society"},{"key":"10.1016\/j.pharmthera.2019.107428_bib0255","doi-asserted-by":"crossref","first-page":"e318","DOI":"10.1097\/CCM.0000000000001616","article-title":"Adjuvant corticosteroid treatment in adults with influenza a (H7N9) viral pneumonia","volume":"44","author":"Cao","year":"2016","journal-title":"Critical Care Medicine"},{"key":"10.1016\/j.pharmthera.2019.107428_bib0260","first-page":"567","article-title":"Budesonide inhaling auxiliary therapy after mycoplasma pneumoniae infection of children","volume":"27","author":"Cao","year":"2007","journal-title":"International Journal of Respiratory"},{"key":"10.1016\/j.pharmthera.2019.107428_bib0265","first-page":"1791","article-title":"Mapracorat, a novel selective glucocorticoid receptor agonist, inhibits hyperosmolar-induced cytokine release and MAPK pathways in human corneal epithelial cells","volume":"16","author":"Cavet","year":"2010","journal-title":"Molecular Vision"},{"key":"10.1016\/j.pharmthera.2019.107428_bib0270","doi-asserted-by":"crossref","first-page":"984","DOI":"10.1183\/13993003.01329-2016","article-title":"Corticosteroids for community-acquired pneumonia: A critical view of the evidence","volume":"48","author":"Chalmers","year":"2016","journal-title":"The European Respiratory Journal"},{"key":"10.1016\/j.pharmthera.2019.107428_bib0275","doi-asserted-by":"crossref","first-page":"2945","DOI":"10.1097\/CCM.0b013e31825fec26","article-title":"Etomidate is associated with mortality and adrenal insufficiency in sepsis: A meta-analysis","volume":"40","author":"Chan","year":"2012","journal-title":"Critical Care Medicine"},{"key":"10.1016\/j.pharmthera.2019.107428_bib0280","first-page":"133","article-title":"Fulminant Mycoplasma pneumoniae pneumonia","volume":"162","author":"Chan","year":"1995","journal-title":"The Western Journal of Medicine"},{"key":"10.1016\/j.pharmthera.2019.107428_bib0285","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1177\/2042018810380214","article-title":"Replication of cortisol circadian rhythm: New advances in hydrocortisone replacement therapy","volume":"1","author":"Chan","year":"2010","journal-title":"Therapeutic Advances in Endocrinology and Metabolism"},{"key":"10.1016\/j.pharmthera.2019.107428_bib0290","doi-asserted-by":"crossref","first-page":"172","DOI":"10.5847\/wjem.j.1920-8642.2015.03.002","article-title":"Efficacy and safety of glucocorticoids in the treatment of community-acquired pneumonia: A meta-analysis of randomized controlled trials","volume":"6","author":"Chen","year":"2015","journal-title":"World Journal of Emergency Medicine"},{"key":"10.1016\/j.pharmthera.2019.107428_bib0295","first-page":"CD007720","article-title":"Corticosteroids for pneumonia","volume":"2011","author":"Chen","year":"2011","journal-title":"The Cochrane Database of Systematic Reviews"},{"key":"10.1016\/j.pharmthera.2019.107428_bib0300","doi-asserted-by":"crossref","first-page":"557","DOI":"10.4187\/respcare.02758","article-title":"Corticosteroid therapy for severe community-acquired pneumonia: A meta-analysis","volume":"59","author":"Cheng","year":"2014","journal-title":"Respiratory Care"},{"key":"10.1016\/j.pharmthera.2019.107428_bib0305","unstructured":"COMP assesses whether Plenadren still meets orphan designation criteria (2016) 1-2). London, United Kingdom: European Medicines Agency."},{"key":"10.1016\/j.pharmthera.2019.107428_bib0310","first-page":"94","article-title":"To use or not to use corticosteroids for pneumonia? A clinician\u2019s perspective","volume":"77","author":"Confalonieri","year":"2012","journal-title":"Monaldi Archives for Chest Disease"},{"key":"10.1016\/j.pharmthera.2019.107428_bib0315","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1164\/rccm.200406-808OC","article-title":"Hydrocortisone infusion for severe community-acquired pneumonia: A preliminary randomized study","volume":"171","author":"Confalonieri","year":"2005","journal-title":"American Journal of Respiratory and Critical Care Medicine"},{"key":"10.1016\/j.pharmthera.2019.107428_bib0320","unstructured":"Corticosteroids: Selection, tapering, and more. Pharmacist\u2019s Letter \/ Prescriber\u2019s Letter (2018). Stockton, CA."},{"key":"10.1016\/j.pharmthera.2019.107428_bib0325","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1053\/j.gastro.2016.02.042","article-title":"NIAAA Alcoholic Hepatitis Consortia. Standard Definitions and Common Data Elements for Clinical Trials in Patients With Alcoholic Hepatitis: Recommendation From the NIAAA Alcoholic Hepatitis Consortia","volume":"150","author":"Crabb","year":"2016","journal-title":"Gastroenterology"},{"key":"10.1016\/j.pharmthera.2019.107428_bib0330","doi-asserted-by":"crossref","first-page":"1430","DOI":"10.1097\/00003246-199508000-00019","article-title":"Corticosteroid treatment for sepsis: A critical appraisal and meta-analysis of the literature","volume":"23","author":"Cronin","year":"1995","journal-title":"Critical Care Medicine"},{"key":"10.1016\/j.pharmthera.2019.107428_bib0335","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1159\/000362724","article-title":"One hormone, two actions: anti- and pro-inflammatory effects of glucocorticoids","volume":"22","author":"Cruz-Topete","year":"2015","journal-title":"Neuroimmunomodulation"},{"key":"10.1016\/j.pharmthera.2019.107428_bib0340","doi-asserted-by":"crossref","first-page":"2080","DOI":"10.1002\/eji.201747044","article-title":"Glucocorticoids downregulate TLR4 signaling activity via its direct targeting by miR-511-5p","volume":"47","author":"Curtale","year":"2017","journal-title":"European Journal of Immunology"},{"key":"10.1016\/j.pharmthera.2019.107428_bib0345","doi-asserted-by":"crossref","first-page":"1868","DOI":"10.1007\/s00134-009-1603-4","article-title":"The effects of etomidate on adrenal responsiveness and mortality in patients with septic shock","volume":"35","author":"Cuthbertson","year":"2009","journal-title":"Intensive Care Medicine"},{"key":"10.1016\/j.pharmthera.2019.107428_bib0350","doi-asserted-by":"crossref","first-page":"410","DOI":"10.4103\/0971-9784.185522","article-title":"Effect of Vitamin C on adrenal suppression by etomidate induction in patients undergoing cardiac surgery: A randomized controlled trial","volume":"19","author":"Das","year":"2016","journal-title":"Annals of Cardiac Anaesthesia"},{"key":"10.1016\/j.pharmthera.2019.107428_bib0355","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1016\/S2213-2600(16)00046-1","article-title":"Genomic landscape of the individual host response and outcomes in sepsis: A prospective cohort study","volume":"4","author":"Davenport","year":"2016","journal-title":"The Lancet Respiratory Medicine"},{"key":"10.1016\/j.pharmthera.2019.107428_bib0360","doi-asserted-by":"crossref","first-page":"670","DOI":"10.1086\/598651","article-title":"Corticosteroids as adjunctive therapy for severe Pneumocystis cariniipneumonia in non-human immunodeficiency virus-infected patients: retrospective study of 31 patients","volume":"29","author":"Delclaux","year":"1999","journal-title":"Clinical Infectious Diseases"},{"key":"10.1016\/j.pharmthera.2019.107428_bib0365","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1007\/s00134-012-2769-8","article-title":"Surviving Sepsis Campaign Guidelines Committee including the Pediatric Subgroup. Surviving Sepsis campaign: International guidelines for management of severe sepsis and septic shock, 2012","volume":"39","author":"Dellinger","year":"2013","journal-title":"Intensive Care Medicine"},{"key":"10.1016\/j.pharmthera.2019.107428_bib0370","doi-asserted-by":"crossref","first-page":"e631","DOI":"10.3928\/01477447-20140626-54","article-title":"Osteonecrosis following short-term, low-dose oral corticosteroids: A population-based study of 24 million patients","volume":"37","author":"Dilisio","year":"2014","journal-title":"Orthopedics"},{"key":"10.1016\/j.pharmthera.2019.107428_bib0375","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1038\/sj.cdd.4400969","article-title":"Recent insights into the mechanism of glucocorticosteroid-induced apoptosis","volume":"9","author":"Distelhorst","year":"2002","journal-title":"Cell Death and Differentiation"},{"key":"10.1016\/j.pharmthera.2019.107428_bib0380","doi-asserted-by":"crossref","first-page":"872","DOI":"10.1086\/515543","article-title":"Adjunctive corticosteroid therapy for tuberculosis: A critical repraisal of the literature","volume":"25","author":"Dooley","year":"1997","journal-title":"Clinical Infectious Diseases"},{"key":"10.1016\/j.pharmthera.2019.107428_bib0385","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1023\/A:1025590308147","article-title":"Glucocorticoid-induced apoptosis in human eosinophils: Mechanisms of action","volume":"8","author":"Druilhe","year":"2003","journal-title":"Apoptosis"},{"key":"10.1016\/j.pharmthera.2019.107428_bib0390","first-page":"2066","article-title":"Glucocorticoids suppress corticotropin-releasing hormone and vasopressin expression in human hypothalamic neurons","volume":"83","author":"Erkut","year":"1998","journal-title":"The Journal of Clinical Endocrinology and Metabolism"},{"key":"10.1016\/j.pharmthera.2019.107428_bib0395","first-page":"CD006150","article-title":"Adjunctive corticosteroids for Pneumocystis jiroveci pneumonia in patients with HIV infection","volume":"4","author":"Ewald","year":"2015","journal-title":"The Cochrane Database of Systematic Reviews"},{"key":"10.1016\/j.pharmthera.2019.107428_bib0400","doi-asserted-by":"crossref","first-page":"698","DOI":"10.1001\/jama.2017.21907","article-title":"Acute respiratory distress syndrome: Advances in diagnosis and treatment","volume":"319","author":"Fan","year":"2018","journal-title":"JAMA"},{"key":"10.1016\/j.pharmthera.2019.107428_bib0405","doi-asserted-by":"crossref","first-page":"2205","DOI":"10.1007\/s00381-017-3536-5","article-title":"Central adrenal insufficiency following traumatic brain injury: A missed diagnosis in the critically injured","volume":"33","author":"Fan","year":"2017","journal-title":"Child's Nervous System"},{"key":"10.1016\/j.pharmthera.2019.107428_bib0410","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1001\/jamainternmed.2018.5849","article-title":"Association of corticosteroid treatment with outcomes in adult patients with Sepsis: A systematic review and meta-analysis","volume":"179","author":"Fang","year":"2019","journal-title":"JAMA Internal Medicine"},{"key":"10.1016\/j.pharmthera.2019.107428_bib0415","series-title":"UpToDate","article-title":"Acute exacerbation of asthma in adults: Emergency department and inpatient management","author":"Fanta","year":"2019"},{"key":"10.1016\/j.pharmthera.2019.107428_bib0420","doi-asserted-by":"crossref","first-page":"1011","DOI":"10.1093\/infdis\/jix052","article-title":"Evaluating the impact of LTA4H genotype and immune status on survival from tuberculous meningitis","volume":"215","author":"Fava","year":"2017","journal-title":"The Journal of Infectious Diseases"},{"key":"10.1016\/j.pharmthera.2019.107428_bib0425","doi-asserted-by":"crossref","first-page":"1344","DOI":"10.1161\/01.STR.0000217375.18081.38","article-title":"Corticosteroids in patients with hemorrhagic stroke","volume":"37","author":"Feigin","year":"2006","journal-title":"Stroke"},{"key":"10.1016\/j.pharmthera.2019.107428_bib0430","doi-asserted-by":"crossref","first-page":"E162","DOI":"10.21037\/jtd.2016.02.43","article-title":"Corticosteroids in the adjunctive therapy of community-acquired pneumonia: An appraisal of recent meta-analyses of clinical trials","volume":"8","author":"Feldman","year":"2016","journal-title":"Journal of Thoracic Disease"},{"key":"10.1016\/j.pharmthera.2019.107428_bib0435","doi-asserted-by":"crossref","first-page":"R96","DOI":"10.1186\/cc10103","article-title":"Effect of corticosteroids on the clinical course of community-acquired pneumonia: A randomized controlled trial","volume":"15","author":"Fern\u00e1ndez-Serrano","year":"2011","journal-title":"Critical Care"},{"key":"10.1016\/j.pharmthera.2019.107428_bib0440","doi-asserted-by":"crossref","first-page":"1283","DOI":"10.1056\/NEJMoa0810625","article-title":"NICE-SUGAR Study Investigators, Intensive versus conventional glucose control in critically ill patients","volume":"360","author":"Finfer","year":"2009","journal-title":"The New England Journal of Medicine"},{"key":"10.1016\/j.pharmthera.2019.107428_bib0445","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/j.arbr.2016.08.002","article-title":"Adjunctive corticosteroids for pneumocystis jirovecii pneumonia in Non-HIV-infected patients: A systematic review and meta-analysis of observational studies","volume":"53","author":"Fujikura","year":"2017","journal-title":"Archivos de Bronconeumologia"},{"key":"10.1016\/j.pharmthera.2019.107428_bib0450","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1079\/BJN2001406","article-title":"Dexamethasone induces sodium-dependant vitamin C transporter in a mouse osteoblastic cell line MC3T3-E1","volume":"86","author":"Fujita","year":"2001","journal-title":"The British Journal of Nutrition"},{"key":"10.1016\/j.pharmthera.2019.107428_bib0455","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1016\/j.jaci.2004.10.036","article-title":"Oral corticosteroids decrease eosinophil and CC chemokine expression but increase neutrophil, IL-8, and IFN-gamma-inducible protein 10 expression in asthmatic airway mucosa","volume":"115","author":"Fukakusa","year":"2005","journal-title":"The Journal of Allergy and Clinical Immunology"},{"key":"10.1016\/j.pharmthera.2019.107428_bib0460","doi-asserted-by":"crossref","first-page":"1444","DOI":"10.1056\/NEJM199011223232103","article-title":"Corticosteroids as adjunctive therapy for severe Pneumocystis carinii pneumonia in the acquired immunodeficiency syndrome. A double-blind, placebo-controlled trial","volume":"323","author":"Gagnon","year":"1990","journal-title":"The New England Journal of Medicine"},{"key":"10.1016\/j.pharmthera.2019.107428_bib0465","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1096\/fj.01-0245com","article-title":"Gene profiling reveals unknown enhancing and suppressive actions of glucocorticoids on immune cells","volume":"16","author":"Galon","year":"2002","journal-title":"FASEB Journal"},{"key":"10.1016\/j.pharmthera.2019.107428_bib0470","doi-asserted-by":"crossref","first-page":"951","DOI":"10.1183\/09031936.00027607","article-title":"Effects of systemic steroids in patients with severe community-acquired pneumonia","volume":"30","author":"Garcia-Vidal","year":"2007","journal-title":"The European Respiratory Journal"},{"key":"10.1016\/j.pharmthera.2019.107428_bib0475","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1016\/j.biomaterials.2018.04.006","article-title":"Glucocorticoid-loaded liposomes induce a pro-resolution phenotype in human primary macrophages to support chronic wound healing","volume":"178","author":"Gauthier","year":"2018","journal-title":"Biomaterials"},{"key":"10.1016\/j.pharmthera.2019.107428_bib0480","doi-asserted-by":"crossref","first-page":"551","DOI":"10.5588\/ijtld.17.0341","article-title":"Systematic review and meta-analysis of adjunctive corticosteroids in the treatment of tuberculous pericarditis","volume":"22","author":"George","year":"2018","journal-title":"The International Journal of Tuberculosis and Lung Disease"},{"key":"10.1016\/j.pharmthera.2019.107428_bib0485","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1186\/s13054-017-1659-4","article-title":"Corticosteroids in septic shock: A systematic review and network meta-analysis","volume":"21","author":"Gibbison","year":"2017","journal-title":"Crit Care"},{"key":"10.1016\/j.pharmthera.2019.107428_bib0490","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1016\/j.jaci.2008.07.007","article-title":"Corticosteroid-resistant asthma is associated with classical antimicrobial activation of airway macrophages","volume":"122","author":"Goleva","year":"2008","journal-title":"The Journal of Allergy and Clinical Immunology"},{"key":"10.1016\/j.pharmthera.2019.107428_bib0495","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1164\/rccm.200507-1046OC","article-title":"Increased glucocorticoid receptor beta alters steroid response in glucocorticoid-insensitive asthma","volume":"173","author":"Goleva","year":"2006","journal-title":"American Journal of Respiratory and Critical Care Medicine"},{"key":"10.1016\/j.pharmthera.2019.107428_bib0500","doi-asserted-by":"crossref","first-page":"1125","DOI":"10.1097\/00003246-199109000-00006","article-title":"Prolonged paralysis after treatment with neuromuscular junction blocking agents","volume":"19","author":"Gooch","year":"1991","journal-title":"Critical Care Medicine"},{"key":"10.1016\/j.pharmthera.2019.107428_bib0505","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1378\/chest.124.2.459","article-title":"Mortality and mortality-related factors after hospitalization for acute exacerbation of COPD","volume":"124","author":"Groenewegen","year":"2003","journal-title":"Chest"},{"key":"10.1016\/j.pharmthera.2019.107428_bib0510","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1378\/chest.14-1012","article-title":"Single-dose etomidate does not increase mortality in patients with sepsis: A systematic review and meta-analysis of randomized controlled trials and observational studies","volume":"147","author":"Gu","year":"2015","journal-title":"Chest"},{"key":"10.1016\/j.pharmthera.2019.107428_bib0515","doi-asserted-by":"crossref","first-page":"4743","DOI":"10.1128\/MCB.24.11.4743-4756.2004","article-title":"Glucocorticoids and tumor necrosis factor alpha cooperatively regulate toll-like receptor 2 gene expression","volume":"24","author":"Hermoso","year":"2004","journal-title":"Molecular and Cellular Biology"},{"key":"10.1016\/j.pharmthera.2019.107428_bib0520","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1111\/ane.12261","article-title":"Glucocorticoids in myasthenia gravis - if, when, how, and how much?","volume":"130","author":"Hoffmann","year":"2014","journal-title":"Acta Neurologica Scandinavica"},{"key":"10.1016\/j.pharmthera.2019.107428_bib0525","doi-asserted-by":"crossref","first-page":"1473","DOI":"10.2169\/internalmedicine.54.4015","article-title":"Impact of corticosteroids on mortality in patients with acute respiratory distress syndrome: A systematic review and meta-analysis","volume":"54","author":"Horita","year":"2015","journal-title":"Internal Medicine"},{"key":"10.1016\/j.pharmthera.2019.107428_bib0530","doi-asserted-by":"crossref","first-page":"14061","DOI":"10.1038\/srep14061","article-title":"Adjunctive systemic corticosteroids for hospitalized community-acquired pneumonia: Systematic review and meta-analysis 2015 update","volume":"5","author":"Horita","year":"2015","journal-title":"Scientific Reports"},{"key":"10.1016\/j.pharmthera.2019.107428_bib0535","doi-asserted-by":"crossref","first-page":"e14636","DOI":"10.1097\/MD.0000000000014636","article-title":"Efficacy and safety of adjunctive corticosteroids therapy for patients with severe community-acquired pneumonia: A systematic review and meta-analysis","volume":"98","author":"Huang","year":"2019","journal-title":"Medicine (Baltimore)"},{"key":"10.1016\/j.pharmthera.2019.107428_bib0540","first-page":"CD001446","article-title":"Corticosteroids for guillain-barre syndrome","author":"Hughes","year":"2016","journal-title":"The Cochrane Database of Systematic Reviews"},{"issue":"Suppl 2","key":"10.1016\/j.pharmthera.2019.107428_bib0545","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1227\/NEU.0b013e31827765c6","article-title":"Pharmacological therapy for acute spinal cord injury","volume":"72","author":"Hurlbert","year":"2013","journal-title":"Neurosurgery"},{"key":"10.1016\/j.pharmthera.2019.107428_bib0550","doi-asserted-by":"crossref","first-page":"e137","DOI":"10.1097\/TXD.0000000000000642","article-title":"A systematic review and meta-analysis of the data behind current recommendations for corticosteroids in Non-HIV-Related PCP: Knowing when you are on shaky foundations","volume":"3","author":"Injean","year":"2017","journal-title":"Transplantation Direct"},{"key":"10.1016\/j.pharmthera.2019.107428_bib0555","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1067\/mai.2002.122465","article-title":"p38 Mitogen-activated protein kinase-induced glucocorticoid receptor phosphorylation reduces its activity: role in steroid-insensitive asthma","volume":"109","author":"Irusen","year":"2002","journal-title":"The Journal of Allergy and Clinical Immunology"},{"key":"10.1016\/j.pharmthera.2019.107428_bib0560","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1084\/jem.20050466","article-title":"Histone deacetylase 2-mediated deacetylation of the glucocorticoid receptor enables NF-kappaB suppression","volume":"203","author":"Ito","year":"2006","journal-title":"The Journal of Experimental Medicine"},{"key":"10.1016\/j.pharmthera.2019.107428_bib0565","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1016\/S0140-6736(09)60949-1","article-title":"KETASED Collaborative Study Group. Etomidate versus ketamine for rapid sequence intubation in acutely ill patients: A multicentre randomised controlled trial","volume":"374","author":"Jabre","year":"2009","journal-title":"Lancet"},{"key":"10.1016\/j.pharmthera.2019.107428_bib0570","doi-asserted-by":"crossref","first-page":"1031","DOI":"10.1378\/chest.127.3.1031","article-title":"Should we use etomidate as an induction agent for endotracheal intubation in patients with septic shock?: A critical appraisal","volume":"127","author":"Jackson","year":"2005","journal-title":"Chest"},{"key":"10.1016\/j.pharmthera.2019.107428_bib0575","doi-asserted-by":"crossref","first-page":"1079","DOI":"10.1164\/ajrccm.160.4.9901075","article-title":"Corticosteroids in acute respiratory failure","volume":"160","author":"Jantz","year":"1999","journal-title":"American Journal of Respiratory and Critical Care Medicine"},{"key":"10.1016\/j.pharmthera.2019.107428_bib0580","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1007\/s00134-010-2121-0","article-title":"Low-dose steroids for septic shock and severe sepsis: The use of Bayesian statistics to resolve clinical trial controversies","volume":"37","author":"Kalil","year":"2011","journal-title":"Intensive Care Medicine"},{"key":"10.1016\/j.pharmthera.2019.107428_bib0585","doi-asserted-by":"crossref","first-page":"738","DOI":"10.1177\/0300060518809783","article-title":"Effectiveness of high-dose glucocorticoids on hemolysis, elevating liver enzymes, and reducing platelets syndrome","volume":"47","author":"Kang","year":"2019","journal-title":"The Journal of International Medical Research"},{"key":"10.1016\/j.pharmthera.2019.107428_bib0590","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1179\/1351000214Y.0000000107","article-title":"Cross-talk between HPA-axis-increased glucocorticoids and mitochondrial stress determines immune responses and clinical manifestations of patients with sepsis","volume":"20","author":"Kasahara","year":"2015","journal-title":"Redox Report"},{"key":"10.1016\/j.pharmthera.2019.107428_bib0595","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1159\/000368802","article-title":"Stress-induced glucocorticoid release upregulates uncoupling Protein-2 expression and enhances resistance to endotoxin-induced lethality","volume":"22","author":"Kasahara","year":"2015","journal-title":"Neuroimmunomodulation"},{"key":"10.1016\/j.pharmthera.2019.107428_bib0600","doi-asserted-by":"crossref","first-page":"1651","DOI":"10.1097\/CCM.0000000000000318","article-title":"Hellenic Sepsis Study Group. Early administration of hydrocortisone replacement after the advent of septic shock: impact on survival and immune response","volume":"42","author":"Katsenos","year":"2014","journal-title":"Critical Care Medicine"},{"key":"10.1016\/j.pharmthera.2019.107428_bib0605","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1164\/rccm.200205-446OC","article-title":"Immunologic and hemodynamic effects of \"low-dose\" hydrocortisone in septic shock: A double-blind, randomized, placebo-controlled, crossover study","volume":"167","author":"Keh","year":"2003","journal-title":"American Journal of Respiratory and Critical Care Medicine"},{"key":"10.1016\/j.pharmthera.2019.107428_bib0610","doi-asserted-by":"crossref","first-page":"1775","DOI":"10.1001\/jama.2016.14799","article-title":"SepNet\u2013Critical Care Trials Group. Effect of hydrocortisone on development of shock among Patients with severe sepsis: The HYPRESS Randomized Clinical Trial","volume":"316","author":"Keh","year":"2016","journal-title":"JAMA"},{"key":"10.1016\/j.pharmthera.2019.107428_bib0615","doi-asserted-by":"crossref","first-page":"797","DOI":"10.2147\/CIA.S200455","article-title":"Refractory healing after surgical therapy of osteonecrosis of the jaw: Associated risk factors in aged patients","volume":"14","author":"Kim","year":"2019","journal-title":"Clinical Interventions in Aging"},{"key":"10.1016\/j.pharmthera.2019.107428_bib0620","doi-asserted-by":"crossref","first-page":"1052","DOI":"10.1164\/rccm.201401-0058OC","article-title":"Outcomes associated with corticosteroid dosage in critically ill patients with acute exacerbations of chronic obstructive pulmonary disease","volume":"189","author":"Kiser","year":"2014","journal-title":"American Journal of Respiratory and Critical Care Medicine"},{"key":"10.1016\/j.pharmthera.2019.107428_bib0625","doi-asserted-by":"crossref","first-page":"160","DOI":"10.4274\/jcrpe.v3i3.31","article-title":"Fetal adrenal suppression due to maternal corticosteroid use: Case report","volume":"3","author":"Kurto\u011flu","year":"2011","journal-title":"Journal of Clinical Research in Pediatric Endocrinology"},{"key":"10.1016\/j.pharmthera.2019.107428_bib0630","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1016\/j.jcrc.2009.08.009","article-title":"Corticosteroid therapy for acute lung injury, acute respiratory distress syndrome, and severe pneumonia: A meta-analysis of randomized controlled trials","volume":"25","author":"Lamontagne","year":"2010","journal-title":"Journal of Critical Care"},{"key":"10.1016\/j.pharmthera.2019.107428_bib0635","doi-asserted-by":"crossref","first-page":"k3284","DOI":"10.1136\/bmj.k3284","article-title":"Corticosteroid therapy for sepsis: A clinical practice guideline","volume":"362","author":"Lamontagne","year":"2018","journal-title":"BMJ"},{"key":"10.1016\/j.pharmthera.2019.107428_bib0640","first-page":"CD010406","article-title":"Corticosteroids as adjunctive therapy in the treatment of influenza","volume":"2","author":"Lansbury","year":"2019","journal-title":"The Cochrane Database of Systematic Reviews"},{"key":"10.1016\/j.pharmthera.2019.107428_bib0645","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1182\/blood-2014-05-552729","article-title":"Current concepts in the diagnosis and management of cytokine release syndrome","volume":"124","author":"Lee","year":"2014","journal-title":"Blood"},{"key":"10.1016\/j.pharmthera.2019.107428_bib0650","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1016\/j.bbadis.2013.05.029","article-title":"Deconstructing the roles of glucocorticoids in adipose tissue biology and the development of central obesity","volume":"1842","author":"Lee","year":"2014","journal-title":"Biochimica et Biophysica Acta"},{"key":"10.1016\/j.pharmthera.2019.107428_bib0655","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1186\/1465-9921-14-87","article-title":"Adjunctive steroid in HIV-negative patients with severe Pneumocystis pneumonia","volume":"14","author":"Lemiale","year":"2013","journal-title":"Respiratory Research"},{"key":"10.1016\/j.pharmthera.2019.107428_bib0660","doi-asserted-by":"crossref","first-page":"2223","DOI":"10.1001\/jama.2013.5023","article-title":"Short-term vs conventional glucocorticoid therapy in acute exacerbations of chronic obstructive pulmonary disease: The REDUCE randomized clinical trial","volume":"309","author":"Leuppi","year":"2013","journal-title":"JAMA"},{"key":"10.1016\/j.pharmthera.2019.107428_bib0665","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1111\/j.1600-0404.1998.tb05968.x","article-title":"Treatment of myasthenia gravis with methylprednisolone pulse: A double blind study","volume":"97","author":"Lindberg","year":"1998","journal-title":"Acta Neurologica Scandinavica"},{"key":"10.1016\/j.pharmthera.2019.107428_bib0670","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1186\/s13045-018-0653-x","article-title":"Cytokine release syndrome: Grading, modeling, and new therapy","volume":"11","author":"Liu","year":"2018","journal-title":"Journal of Hematology & Oncology"},{"key":"10.1016\/j.pharmthera.2019.107428_bib0675","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1007\/s12016-011-8274-y","article-title":"The critically ill asthmatic--from ICU to discharge","volume":"43","author":"Louie","year":"2012","journal-title":"Clinical Reviews in Allergy & Immunology"},{"key":"10.1016\/j.pharmthera.2019.107428_bib0680","doi-asserted-by":"crossref","first-page":"1348","DOI":"10.1002\/hep.21607","article-title":"The Lille model: A new tool for therapeutic strategy in patients with severe alcoholic hepatitis treated with steroids","volume":"45","author":"Louvet","year":"2007","journal-title":"Hepatology"},{"key":"10.1016\/j.pharmthera.2019.107428_bib0685","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1053\/j.gastro.2018.05.011","article-title":"Corticosteroids reduce risk of death within 28 days for patients with severe alcoholic hepatitis, compared with pentoxifylline or Placebo-a meta-analysis of individual data from controlled trials","volume":"155","author":"Louvet","year":"2018","journal-title":"Gastroenterology"},{"key":"10.1016\/j.pharmthera.2019.107428_bib0690","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1196\/annals.1321.008","article-title":"The origin and functions of multiple human glucocorticoid receptor isoforms","volume":"1024","author":"Lu","year":"2004","journal-title":"Ann NY Acad Sci"},{"key":"10.1016\/j.pharmthera.2019.107428_bib0695","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1164\/ajrccm\/138.1.62","article-title":"Ineffectiveness of high-dose methylprednisolone in preventing parenchymal lung injury and improving mortality in patients with septic shock","volume":"138","author":"Luce","year":"1988","journal-title":"The American Review of Respiratory Disease"},{"key":"10.1016\/j.pharmthera.2019.107428_bib0700","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/0016-5085(78)90401-8","article-title":"Corticosteroid therapy of alcoholic hepatitis","volume":"75","author":"Maddrey","year":"1978","journal-title":"Gastroenterology"},{"key":"10.1016\/j.pharmthera.2019.107428_bib0705","doi-asserted-by":"crossref","first-page":"1473","DOI":"10.1056\/NEJM199205283262206","article-title":"Nontraumatic necrosis of bone (osteonecrosis)","volume":"326","author":"Mankin","year":"1992","journal-title":"The New England Journal of Medicine"},{"key":"10.1016\/j.pharmthera.2019.107428_bib0710","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1378\/chest.104.2.389","article-title":"Hydrocortisone and tumor necrosis factor in severe community-acquired pneumonia. A randomized controlled study","volume":"104","author":"Marik","year":"1993","journal-title":"Chest"},{"key":"10.1016\/j.pharmthera.2019.107428_bib0715","doi-asserted-by":"crossref","first-page":"1266","DOI":"10.1097\/00003246-199607000-00034","article-title":"Doxacurium-corticosteroid acute myopathy: Another piece to the puzzle","volume":"24","author":"Marik","year":"1996","journal-title":"Critical Care Medicine"},{"key":"10.1016\/j.pharmthera.2019.107428_bib0720","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1097\/CCM.0b013e318232647f","article-title":"Etomidate in critically ill patients. is it safe?","volume":"40","author":"Marik","year":"2012","journal-title":"Critical Care Medicine"},{"key":"10.1016\/j.pharmthera.2019.107428_bib0725","doi-asserted-by":"crossref","first-page":"1433","DOI":"10.1097\/CCM.0000000000001683","article-title":"Precision glycemic control in the ICU","volume":"44","author":"Marik","year":"2016","journal-title":"Critical Care Medicine"},{"key":"10.1016\/j.pharmthera.2019.107428_bib0730","doi-asserted-by":"crossref","first-page":"1475","DOI":"10.1007\/s00134-016-4299-2","article-title":"Tight glycemic control in acutely ill patients: low evidence of benefit, high evidence of harm!","volume":"42","author":"Marik","year":"2016","journal-title":"Intensive Care Medicine"},{"key":"10.1016\/j.pharmthera.2019.107428_bib0735","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1016\/S2213-2600(18)30265-0","article-title":"The role of glucocorticoids as adjunctive treatment for sepsis in the modern era","volume":"6","author":"Marik","year":"2018","journal-title":"The Lancet Respiratory Medicine"},{"key":"10.1016\/j.pharmthera.2019.107428_bib0740","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1186\/cc12514","article-title":"Stress hyperglycemia: An essential survival response!","volume":"17","author":"Marik","year":"2013","journal-title":"Critical Care"},{"key":"10.1016\/j.pharmthera.2019.107428_bib0745","doi-asserted-by":"crossref","first-page":"1937","DOI":"10.1097\/CCM.0b013e31817603ba","article-title":"Recommendations for the diagnosis and management of corticosteroid insufficiency in critically ill adult patients: Consensus statements from an international task force by the American College of Critical Care Medicine","volume":"36","author":"Marik","year":"2008","journal-title":"Critical Care Medicine"},{"key":"10.1016\/j.pharmthera.2019.107428_bib0750","first-page":"701","article-title":"Corticosteroids and gastrointestinal bleeding in critical care: A systematic review and meta-analysis","volume":"22","author":"Marik","year":"2019","journal-title":"Critical Care and Shock"},{"key":"10.1016\/j.pharmthera.2019.107428_bib0755","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1378\/chest.09-1737","article-title":"Toward understanding tight glycemic control in the ICU: A systematic review and metaanalysis","volume":"137","author":"Marik","year":"2010","journal-title":"Chest"},{"key":"10.1016\/j.pharmthera.2019.107428_bib0760","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0144032","article-title":"Adjunctive corticotherapy for community acquired pneumonia: A systematic review and meta-analysis","volume":"10","author":"Marti","year":"2015","journal-title":"PloS One"},{"key":"10.1016\/j.pharmthera.2019.107428_bib0765","doi-asserted-by":"crossref","first-page":"2252","DOI":"10.1053\/j.jvca.2018.04.017","article-title":"Steroids and survival in critically ill adult patients: A meta-analysis of 135 randomized trials","volume":"32","author":"Martino","year":"2018","journal-title":"Journal of Cardiothoracic and Vascular Anesthesia"},{"key":"10.1016\/j.pharmthera.2019.107428_bib0770","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1136\/gut.2010.224097","article-title":"Corticosteroids improve short-term survival in patients with severe alcoholic hepatitis: Meta-analysis of individual patient data","volume":"60","author":"Mathurin","year":"2011","journal-title":"Gut"},{"key":"10.1016\/j.pharmthera.2019.107428_bib0775","doi-asserted-by":"crossref","first-page":"1100","DOI":"10.1016\/j.jaci.2004.03.018","article-title":"Defective glucocorticoid receptor nuclear translocation and altered histone acetylation patterns in glucocorticoid-resistant patients","volume":"113","author":"Matthews","year":"2004","journal-title":"The Journal of Allergy and Clinical Immunology"},{"key":"10.1016\/j.pharmthera.2019.107428_bib0780","doi-asserted-by":"crossref","first-page":"1121","DOI":"10.1056\/NEJMoa1407380","article-title":"IMPI Trial Investigators. Prednisolone and Mycobacterium indicus pranii in tuberculous pericarditis","volume":"371","author":"Mayosi","year":"2014","journal-title":"The New England Journal of Medicine"},{"key":"10.1016\/j.pharmthera.2019.107428_bib0785","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1136\/bmj.4.5840.569","article-title":"Ampicillin dosage and use of prednisolone in treatment of pneumonia: Co-operative controlled trial","volume":"4","author":"McHardy","year":"1972","journal-title":"British Medical Journal"},{"key":"10.1016\/j.pharmthera.2019.107428_bib0790","series-title":"Holland-frei cancer medicine","article-title":"Physiologic and pharmacologic effects of corticosteroids","author":"McKay","year":"2003"},{"key":"10.1016\/j.pharmthera.2019.107428_bib0795","doi-asserted-by":"crossref","first-page":"774","DOI":"10.1097\/CCM.0b013e318274190d","article-title":"Single-dose etomidate is not associated with increased mortality in ICU patients with sepsis: Analysis of a large electronic ICU database","volume":"41","author":"McPhee","year":"2013","journal-title":"Critical Care Medicine"},{"key":"10.1016\/j.pharmthera.2019.107428_bib0800","doi-asserted-by":"crossref","first-page":"e543","DOI":"10.1016\/j.lpm.2011.04.023","article-title":"Pathophysiology of acute respiratory distress syndrome. Glucocorticoid receptor-mediated regulation of inflammation and response to prolonged glucocorticoid treatment","volume":"40","author":"Meduri","year":"2011","journal-title":"Presse Med"},{"key":"10.1016\/j.pharmthera.2019.107428_bib0805","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1007\/s00134-015-4095-4","article-title":"Prolonged glucocorticoid treatment is associated with improved ARDS outcomes: Analysis of individual patients\u2019 data from four randomized trials and trial-level meta-analysis of the updated literature","volume":"42","author":"Meduri","year":"2016","journal-title":"Intensive Care Medicine"},{"key":"10.1016\/j.pharmthera.2019.107428_bib0810","doi-asserted-by":"crossref","first-page":"884","DOI":"10.1097\/CCM.0000000000003021","article-title":"An exploratory reanalysis of the randomized trial on efficacy of corticosteroids as rescue therapy for the late phase of acute respiratory distress syndrome","volume":"46","author":"Meduri","year":"2018","journal-title":"Critical Care Medicine"},{"key":"10.1016\/j.pharmthera.2019.107428_bib0815","doi-asserted-by":"crossref","first-page":"954","DOI":"10.1378\/chest.06-2100","article-title":"Methylprednisolone infusion in early severe ARDS: Results of a randomized controlled trial","volume":"131","author":"Meduri","year":"2007","journal-title":"Chest"},{"key":"10.1016\/j.pharmthera.2019.107428_bib0820","doi-asserted-by":"crossref","first-page":"1156","DOI":"10.1128\/CDLI.8.6.1156-1163.2001","article-title":"Effects of methylprednisolone on intracellular bacterial growth","volume":"8","author":"Meduri","year":"2001","journal-title":"Clinical and Diagnostic Laboratory Immunology"},{"key":"10.1016\/j.pharmthera.2019.107428_bib0825","doi-asserted-by":"crossref","first-page":"1093","DOI":"10.1378\/chest.07-0714","article-title":"Corticosteroids in ARDS: A counterpoint","volume":"132","author":"Meduri","year":"2007","journal-title":"Chest"},{"key":"10.1016\/j.pharmthera.2019.107428_bib0830","doi-asserted-by":"crossref","first-page":"2023","DOI":"10.1016\/S0140-6736(11)60607-7","article-title":"Dexamethasone and length of hospital stay in patients with community-acquired pneumonia: A randomised, double-blind, placebo-controlled trial","volume":"377","author":"Meijvis","year":"2011","journal-title":"Lancet"},{"key":"10.1016\/j.pharmthera.2019.107428_bib0835","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1001\/jama.2013.7832","article-title":"Vasopressin, steroids, and epinephrine and neurologically favorable survival after in-hospital cardiac arrest: A randomized clinical trial","volume":"310","author":"Mentzelopoulos","year":"2013","journal-title":"JAMA"},{"key":"10.1016\/j.pharmthera.2019.107428_bib0840","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1001\/archinternmed.2008.509","article-title":"Vasopressin, epinephrine, and corticosteroids for in-hospital cardiac arrest","volume":"169","author":"Mentzelopoulos","year":"2009","journal-title":"Archives of Internal Medicine"},{"key":"10.1016\/j.pharmthera.2019.107428_bib0845","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0041582","article-title":"Restoration of corticosteroid sensitivity by p38 mitogen activated protein kinase inhibition in peripheral blood mononuclear cells from severe asthma","volume":"7","author":"Mercado","year":"2012","journal-title":"PloS One"},{"key":"10.1016\/j.pharmthera.2019.107428_bib0850","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1007\/s11910-017-0796-0","article-title":"Tuberculous meningitis in children and adults: New insights for an ancient foe","volume":"17","author":"Mezochow","year":"2017","journal-title":"Current Neurology and Neuroscience Reports"},{"key":"10.1016\/j.pharmthera.2019.107428_bib0855","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1007\/s11010-010-0592-5","article-title":"Reciprocal regulation of 11\u03b2-hydroxysteroid dehydrogenase 1 and glucocorticoid receptor expression by dexamethasone inhibits human coronary artery smooth muscle cell proliferation in vitro","volume":"346","author":"Michas","year":"2011","journal-title":"Molecular and Cellular Biochemistry"},{"key":"10.1016\/j.pharmthera.2019.107428_bib0860","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1007\/s00408-007-9020-3","article-title":"Efficacy of corticosteroids in the treatment of community-acquired pneumonia requiring hospitalization","volume":"185","author":"Mikami","year":"2007","journal-title":"Lung"},{"key":"10.1016\/j.pharmthera.2019.107428_bib0865","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1111\/j.1365-2222.2011.03715.x","article-title":"Oxidative stress-induced glucocorticoid resistance is prevented by dual PDE3\/PDE4 inhibition in human alveolar macrophages","volume":"41","author":"Milara","year":"2011","journal-title":"Clinical and Experimental Allergy"},{"key":"10.1016\/j.pharmthera.2019.107428_bib0870","doi-asserted-by":"crossref","first-page":"824","DOI":"10.1016\/j.jaci.2008.12.019","article-title":"Parental support and cytokine activity in childhood asthma: The role of glucocorticoid sensitivity","volume":"123","author":"Miller","year":"2009","journal-title":"The Journal of Allergy and Clinical Immunology"},{"key":"10.1016\/j.pharmthera.2019.107428_bib0875","doi-asserted-by":"crossref","first-page":"65","DOI":"10.7874\/kja.2012.16.2.65","article-title":"Characteristics of adverse effects when using high dose short term steroid regimen","volume":"16","author":"Min","year":"2012","journal-title":"Korean Journal of Audiology"},{"key":"10.1016\/j.pharmthera.2019.107428_bib0880","doi-asserted-by":"crossref","first-page":"47","DOI":"10.7326\/0003-4819-141-1-200407060-00014","article-title":"Meta-analysis: The effect of steroids on survival and shock during sepsis depends on the dose","volume":"141","author":"Minneci","year":"2004","journal-title":"Annals of Internal Medicine"},{"key":"10.1016\/j.pharmthera.2019.107428_bib0885","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1111\/j.1469-0691.2009.02752.x","article-title":"The effects of steroids during sepsis depend on dose and severity of illness: An updated meta-analysis","volume":"15","author":"Minneci","year":"2009","journal-title":"Clinical Microbiology and Infection"},{"key":"10.1016\/j.pharmthera.2019.107428_bib0890","first-page":"1","article-title":"Genomic and non-genomic effects of glucocorticoids: Implications for breast cancer","volume":"8","author":"Mitre-Aguilar","year":"2015","journal-title":"International Journal of Clinical and Experimental Pathology"},{"key":"10.1016\/j.pharmthera.2019.107428_bib0895","doi-asserted-by":"crossref","first-page":"14","DOI":"10.7326\/0003-4819-113-1-14","article-title":"Corticosteroids prevent early deterioration in patients with moderately severe Pneumocystis carinii pneumonia and the acquired immunodeficiency syndrome (AIDS)","volume":"113","author":"Montaner","year":"1990","journal-title":"Annals of Internal Medicine"},{"key":"10.1016\/j.pharmthera.2019.107428_bib0900","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1124\/dmd.112.046318","article-title":"Metabolic pathways of inhaled glucocorticoids by the CYP3A enzymes","volume":"41","author":"Moore","year":"2013","journal-title":"Drug Metabolism and Disposition: the Biological Fate of Chemicals"},{"key":"10.1016\/j.pharmthera.2019.107428_bib0905","doi-asserted-by":"crossref","first-page":"R134","DOI":"10.1186\/cc9182","article-title":"Updating the evidence for the role of corticosteroids in severe sepsis and septic shock: A Bayesian meta-analytic perspective","volume":"14","author":"Moran","year":"2010","journal-title":"Critical Care"},{"key":"10.1016\/j.pharmthera.2019.107428_bib0910","doi-asserted-by":"crossref","first-page":"1470","DOI":"10.1007\/s00134-018-5332-4","article-title":"GETGAG Study Group. Corticosteroid treatment in critically ill patients with severe influenza pneumonia: A propensity score matching study","volume":"44","author":"Moreno","year":"2018","journal-title":"Intensive Care Medicine"},{"key":"10.1016\/j.pharmthera.2019.107428_bib0915","doi-asserted-by":"crossref","first-page":"2506","DOI":"10.2337\/db09-0525","article-title":"11beta-hydroxysteroid dehydrogenase type 1 regulates glucocorticoid-induced insulin resistance in skeletal muscle","volume":"58","author":"Morgan","year":"2009","journal-title":"Diabetes"},{"key":"10.1016\/j.pharmthera.2019.107428_bib0920","doi-asserted-by":"crossref","first-page":"2101","DOI":"10.1182\/blood-2015-09-670729","article-title":"Dexamethasone vs prednisone in induction treatment of pediatric ALL: Results of the randomized trial AIEOP-BFM ALL 2000","volume":"127","author":"M\u00f6ricke","year":"2016","journal-title":"Blood"},{"key":"10.1016\/j.pharmthera.2019.107428_bib0925","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1016\/j.ejcdt.2013.03.009","article-title":"Adjuvant role of corticosteroids in the treatment of community-acquired pneumonia","volume":"62","author":"Nafae","year":"2013","journal-title":"Egyptian J Chest Dis Tuberc"},{"key":"10.1016\/j.pharmthera.2019.107428_bib0930","doi-asserted-by":"crossref","first-page":"2431","DOI":"10.1056\/NEJMoa070852","article-title":"Dexamethasone in Vietnamese adolescents and adults with bacterial meningitis","volume":"357","author":"Nguyen","year":"2007","journal-title":"The New England Journal of Medicine"},{"key":"10.1016\/j.pharmthera.2019.107428_bib0935","doi-asserted-by":"crossref","first-page":"1781","DOI":"10.1056\/NEJMoa1101214","article-title":"AAH-NAC Study Group. Glucocorticoids plus N-acetylcysteine in severe alcoholic hepatitis","volume":"365","author":"Nguyen-Khac","year":"2011","journal-title":"The New England Journal of Medicine"},{"key":"10.1016\/j.pharmthera.2019.107428_bib0940","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1186\/s13054-017-1656-7","article-title":"ProHOSP Study Group. Time-dependent association of glucocorticoids with adverse outcome in community-acquired pneumonia: A 6-year prospective cohort study","volume":"21","author":"Nickler","year":"2017","journal-title":"Crit Care"},{"key":"10.1016\/j.pharmthera.2019.107428_bib0945","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0047926","article-title":"Corticosteroids in the treatment of community-acquired pneumonia in adults: A meta-analysis","volume":"7","author":"Nie","year":"2012","journal-title":"PloS One"},{"key":"10.1016\/j.pharmthera.2019.107428_bib0950","doi-asserted-by":"crossref","first-page":"871","DOI":"10.1097\/MCG.0000000000000585","article-title":"Corticosteroids versus pentoxifylline for severe alcoholic hepatitis: A sequential analysis of randomized controlled trials","volume":"50","author":"Njei","year":"2016","journal-title":"Journal of Clinical Gastroenterology"},{"key":"10.1016\/j.pharmthera.2019.107428_bib0955","first-page":"28","article-title":"Effect of vitamin C on serum cortisol after etomidate induction of anesthesia","volume":"1","author":"Nooraei","year":"2016","journal-title":"J Cell Mol Anesthesia"},{"key":"10.1016\/j.pharmthera.2019.107428_bib0960","first-page":"CD011801","article-title":"Different oral corticosteroid regimens for acute asthma","author":"Normansell","year":"2016","journal-title":"The Cochrane Database of Systematic Reviews"},{"key":"10.1016\/j.pharmthera.2019.107428_bib0965","doi-asserted-by":"crossref","first-page":"1033","DOI":"10.1016\/j.jaci.2013.09.007","article-title":"The biology of the glucocorticoid receptor: New signaling mechanisms in health and disease","volume":"132","author":"Oakley","year":"2013","journal-title":"The Journal of Allergy and Clinical Immunology"},{"key":"10.1016\/j.pharmthera.2019.107428_bib0970","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/S0006-2952(98)00121-X","volume":"56","author":"Okamoto","year":"1998","journal-title":"Biochemical Pharmacology"},{"key":"10.1016\/j.pharmthera.2019.107428_bib0975","doi-asserted-by":"crossref","first-page":"1107","DOI":"10.1056\/NEJMoa1005372","article-title":"ACURASYS Study Investigators. Neuromuscular blockers in early acute respiratory distress syndrome","volume":"363","author":"Papazian","year":"2010","journal-title":"The New England Journal of Medicine"},{"key":"10.1016\/j.pharmthera.2019.107428_bib0980","doi-asserted-by":"crossref","first-page":"1215","DOI":"10.1378\/chest.113.5.1215","article-title":"Use of adjunctive corticosteroids in severe adult non-HIV Pneumocystis carinii pneumonia","volume":"113","author":"Pareja","year":"1998","journal-title":"Chest"},{"key":"10.1016\/j.pharmthera.2019.107428_bib0985","doi-asserted-by":"crossref","first-page":"999","DOI":"10.1210\/me.2014-1062","article-title":"Minireview: New molecular mediators of glucocorticoid receptor activity in metabolic tissues","volume":"28","author":"Patel","year":"2014","journal-title":"Molecular Endocrinology"},{"key":"10.1016\/j.pharmthera.2019.107428_bib0990","first-page":"CD001511","article-title":"Glucocorticosteroids for people with alcoholic hepatitis","volume":"4","author":"Pavlov","year":"2019","journal-title":"The Cochrane Database of Systematic Reviews"},{"key":"10.1016\/j.pharmthera.2019.107428_bib0995","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1097\/CCM.0b013e31822d7938","article-title":"Corticosteroid after etomidate in critically ill patients: A randomized controlled trial","volume":"40","author":"Payen","year":"2012","journal-title":"Critical Care Medicine"},{"key":"10.1016\/j.pharmthera.2019.107428_bib1000","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1136\/bmj.39537.939039.BE","article-title":"Corticosteroids in the prevention and treatment of acute respiratory distress syndrome (ARDS) in adults: Meta-analysis","volume":"336","author":"Peter","year":"2008","journal-title":"BMJ"},{"key":"10.1016\/j.pharmthera.2019.107428_bib1005","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1128\/MMBR.00064-15","article-title":"The interactome of the glucocorticoid receptor and its influence on the actions of glucocorticoids in combatting inflammatory and infectious diseases","volume":"80","author":"Petta","year":"2016","journal-title":"Microbiology and Molecular Biology Reviews"},{"key":"10.1016\/j.pharmthera.2019.107428_bib1010","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1016\/j.chest.2018.11.001","article-title":"The cost-effectiveness of corticosteroids for the treatment of community-acquired pneumonia","volume":"155","author":"Pliakos","year":"2019","journal-title":"Chest"},{"key":"10.1016\/j.pharmthera.2019.107428_bib1015","first-page":"CD011940","article-title":"Adverse side effects of dexamethasone in surgical patients","volume":"11","author":"Polderman","year":"2018","journal-title":"The Cochrane Database of Systematic Reviews"},{"key":"10.1016\/j.pharmthera.2019.107428_bib1020","doi-asserted-by":"crossref","first-page":"1229","DOI":"10.1056\/NEJM198705143162001","article-title":"Effects of dexamethasone in primary supratentorial intracerebral hemorrhage","volume":"316","author":"Poungvarin","year":"1987","journal-title":"The New England Journal of Medicine"},{"key":"10.1016\/j.pharmthera.2019.107428_bib1025","first-page":"CD002244","article-title":"Corticosteroids for managing tuberculous meningitis","volume":"4","author":"Prasad","year":"2016","journal-title":"The Cochrane Database of Systematic Reviews"},{"key":"10.1016\/j.pharmthera.2019.107428_bib1030","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1186\/s13054-016-1442-y","article-title":"New aspects in the management of pneumonia","volume":"20","author":"Prina","year":"2016","journal-title":"Crit Care"},{"key":"10.1016\/j.pharmthera.2019.107428_bib1035","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1042\/BJ20090107","article-title":"Interaction of mitochondrial thioredoxin with glucocorticoid receptor and NF-kappaB modulates glucocorticoid receptor and NF-kappaB signalling in HEK-293 cells","volume":"422","author":"Psarra","year":"2009","journal-title":"The Biochemical Journal"},{"key":"10.1016\/j.pharmthera.2019.107428_bib1040","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1016\/j.bbabio.2008.11.011","article-title":"Glucocorticoid receptors and other nuclear transcription factors in mitochondria and possible functions","volume":"1787","author":"Psarra","year":"2009","journal-title":"Biochimica et Biophysica Acta"},{"key":"10.1016\/j.pharmthera.2019.107428_bib1045","doi-asserted-by":"crossref","first-page":"1814","DOI":"10.1016\/j.bbamcr.2011.05.014","article-title":"Glucocorticoids induce mitochondrial gene transcription in HepG2 cells: Role of the mitochondrial glucocorticoid receptor","volume":"1813","author":"Psarra","year":"2011","journal-title":"Biochimica et Biophysica Acta"},{"key":"10.1016\/j.pharmthera.2019.107428_bib1050","doi-asserted-by":"crossref","first-page":"1167","DOI":"10.1111\/j.1365-2036.2008.03685.x","article-title":"Systematic review: Glucocorticosteroids for alcoholic hepatitis--A Cochrane Hepato-Biliary Group systematic review with meta-analyses and trial sequential analyses of randomized clinical trials","volume":"27","author":"Rambaldi","year":"2008","journal-title":"Alimentary Pharmacology & Therapeutics"},{"key":"10.1016\/j.pharmthera.2019.107428_bib1055","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1056\/NEJM199202203260802","article-title":"A randomized trial of prednisolone in patients with severe alcoholic hepatitis","volume":"326","author":"Ramond","year":"1992","journal-title":"The New England Journal of Medicine"},{"key":"10.1016\/j.pharmthera.2019.107428_bib1060","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1136\/hrt.82.2.246","article-title":"Recurrent pericardial effusion: The value of polymerase chain reaction in the diagnosis of tuberculosis","volume":"82","author":"Rana","year":"1999","journal-title":"Heart"},{"key":"10.1016\/j.pharmthera.2019.107428_bib1065","first-page":"2526","article-title":"ARDS definition task force. Acute respiratory distress syndrome: The Berlin definition","volume":"307","author":"Ranieri","year":"2012","journal-title":"JAMA"},{"key":"10.1016\/j.pharmthera.2019.107428_bib1070","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1016\/j.clinbiochem.2004.11.009","article-title":"The mechanisms of differential glucocorticoid and mineralocorticoid action in the brain and peripheral tissues","volume":"38","author":"Rashid","year":"2005","journal-title":"Clinical Biochemistry"},{"key":"10.1016\/j.pharmthera.2019.107428_bib1075","doi-asserted-by":"crossref","first-page":"1340","DOI":"10.1016\/j.ajem.2015.07.062","article-title":"Risk factors for mortality in septic patients who received etomidate","volume":"33","author":"Rech","year":"2015","journal-title":"The American Journal of Emergency Medicine"},{"key":"10.1016\/j.pharmthera.2019.107428_bib1080","doi-asserted-by":"crossref","first-page":"1411","DOI":"10.1097\/CCM.0000000000003262","article-title":"Corticosteroids in Sepsis: An updated systematic review and meta-analysis","volume":"46","author":"Rochwerg","year":"2018","journal-title":"Critical Care Medicine"},{"key":"10.1016\/j.pharmthera.2019.107428_bib1085","doi-asserted-by":"crossref","first-page":"1201","DOI":"10.1001\/jama.2011.360","article-title":"Hydrocortisone therapy for patients with multiple trauma: The randomized controlled HYPOLYTE study","volume":"305","author":"Roquilly","year":"2011","journal-title":"JAMA"},{"key":"10.1016\/j.pharmthera.2019.107428_bib1090","doi-asserted-by":"crossref","first-page":"R63","DOI":"10.1186\/cc13819","article-title":"Exploring the heterogeneity of effects of corticosteroids on acute respiratory distress syndrome: A systematic review and meta-analysis","volume":"18","author":"Ruan","year":"2014","journal-title":"Crit Care"},{"key":"10.1016\/j.pharmthera.2019.107428_bib1095","doi-asserted-by":"crossref","first-page":"1003","DOI":"10.1007\/s00134-018-5197-6","article-title":"Low-dose corticosteroids for adult patients with septic shock: A systematic review with meta-analysis and trial sequential analysis","volume":"44","author":"Ryg\u00e5rd","year":"2018","journal-title":"Intensive Care Medicine"},{"key":"10.1016\/j.pharmthera.2019.107428_bib1100","doi-asserted-by":"crossref","first-page":"73","DOI":"10.4236\/pp.2011.22009","article-title":"Corticosteroids and ICU-course of community acquired pneumonia in Egyptian settings","volume":"2","author":"Sabry","year":"2011","journal-title":"Pharmacology & Pharmacy"},{"key":"10.1016\/j.pharmthera.2019.107428_bib1105","doi-asserted-by":"crossref","first-page":"R76","DOI":"10.1186\/cc6922","article-title":"The role of corticosteroids in severe community-acquired pneumonia: A systematic review","volume":"12","author":"Salluh","year":"2008","journal-title":"Crit Care"},{"key":"10.1016\/j.pharmthera.2019.107428_bib1110","doi-asserted-by":"crossref","DOI":"10.1016\/j.jcrc.2010.03.004","article-title":"Cortisol levels and adrenal response in severe community-acquired pneumonia: A systematic review of the literature","volume":"25","author":"Salluh","year":"2010","journal-title":"Journal of Critical Care"},{"key":"10.1016\/j.pharmthera.2019.107428_bib1115","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/j.jcrc.2010.07.014","article-title":"Impact of systemic corticosteroids on the clinical course and outcomes of patients with severe community-acquired pneumonia: A cohort study","volume":"26","author":"Salluh","year":"2011","journal-title":"Journal of Critical Care"},{"key":"10.1016\/j.pharmthera.2019.107428_bib1120","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1186\/cc10099","article-title":"Corticosteroids in severe community-acquired pneumonia: The path we choose depends on where we want to get","volume":"15","author":"Salluh","year":"2011","journal-title":"Crit Care"},{"key":"10.1016\/j.pharmthera.2019.107428_bib1125","unstructured":"Sasse, S. K., Gruca, M., Allen, M. A., Kadiyala, V., Song, T., Gally, F. et al. (2019). BioRxiv. BioRxiv, Pre-print."},{"key":"10.1016\/j.pharmthera.2019.107428_bib1130","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0104953","article-title":"Hydrocortisone fails to abolish NF-\u03baB1 protein nuclear translocation in deletion allele carriers of the NFKB1 promoter polymorphism (-94ins\/delATTG) and is associated with increased 30-day mortality in septic shock","volume":"9","author":"Sch\u00e4fer","year":"2014","journal-title":"PloS One"},{"key":"10.1016\/j.pharmthera.2019.107428_bib1135","doi-asserted-by":"crossref","first-page":"850","DOI":"10.1378\/chest.91.6.850","article-title":"Complement activation and corticosteroid therapy in the development of the adult respiratory distress syndrome","volume":"91","author":"Schein","year":"1987","journal-title":"Chest"},{"key":"10.1016\/j.pharmthera.2019.107428_bib1140","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1097\/00000658-197609000-00011","article-title":"Steroids in the treatment of clinical septic shock","volume":"184","author":"Schumer","year":"1976","journal-title":"Annals of Surgery"},{"key":"10.1016\/j.pharmthera.2019.107428_bib1145","first-page":"43","article-title":"Are corticosteroids useful in late-stage acute respiratory distress syndrome?","volume":"55","author":"Sessler","year":"2010","journal-title":"Respiratory Care"},{"key":"10.1016\/j.pharmthera.2019.107428_bib1150","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1002\/jhm.1992","article-title":"Adjuvant steroid therapy in community-acquired pneumonia: A systematic review and meta-analysis","volume":"8","author":"Shafiq","year":"2013","journal-title":"Journal of Hospital Medicine"},{"key":"10.1016\/j.pharmthera.2019.107428_bib1155","doi-asserted-by":"crossref","first-page":"1037","DOI":"10.1183\/09031936.00009208","article-title":"Effects of glucocorticoids in ventilated piglets with severe pneumonia","volume":"32","author":"Sibila","year":"2008","journal-title":"The European Respiratory Journal"},{"key":"10.1016\/j.pharmthera.2019.107428_bib1160","doi-asserted-by":"crossref","first-page":"519","DOI":"10.7326\/M15-0715","article-title":"Corticosteroid therapy for patients hospitalized with community-acquired pneumonia: A systematic review and meta-analysis","volume":"163","author":"Siemieniuk","year":"2015","journal-title":"Annals of Internal Medicine"},{"key":"10.1016\/j.pharmthera.2019.107428_bib1165","doi-asserted-by":"crossref","first-page":"534","DOI":"10.1016\/j.jhep.2018.05.001","article-title":"Grand rounds: Alcoholic hepatitis","volume":"69","author":"Singal","year":"2018","journal-title":"Journal of Hepatology"},{"key":"10.1016\/j.pharmthera.2019.107428_bib1170","doi-asserted-by":"crossref","first-page":"205","DOI":"10.4254\/wjh.v3.i8.205","article-title":"Corticosteroids and pentoxifylline for the treatment of alcoholic hepatitis: Current status","volume":"3","author":"Singal","year":"2011","journal-title":"World Journal of Hepatology"},{"key":"10.1016\/j.pharmthera.2019.107428_bib1175","doi-asserted-by":"crossref","first-page":"958","DOI":"10.1053\/j.gastro.2015.06.006","article-title":"Comparative effectiveness of pharmacological interventions for severe alcoholic hepatitis: A systematic review and network meta-analysis","volume":"149","author":"Singh","year":"2015","journal-title":"Gastroenterology"},{"key":"10.1016\/j.pharmthera.2019.107428_bib1180","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1086\/599343","article-title":"Safety and efficacy of corticosteroids for the treatment of septic shock: A systematic review and meta-analysis","volume":"49","author":"Sligl","year":"2009","journal-title":"Clinical Infectious Diseases"},{"key":"10.1016\/j.pharmthera.2019.107428_bib1185","doi-asserted-by":"crossref","first-page":"975","DOI":"10.1164\/rccm.200905-0808OC","article-title":"Efficacy of corticosteroids in community-acquired pneumonia: A randomized double-blinded clinical trial","volume":"181","author":"Snijders","year":"2010","journal-title":"American Journal of Respiratory and Critical Care Medicine"},{"key":"10.1016\/j.pharmthera.2019.107428_bib1190","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1056\/NEJMoa071366","article-title":"CORTICUS Study Group. Hydrocortisone therapy for patients with septic shock","volume":"358","author":"Sprung","year":"2008","journal-title":"The New England Journal of Medicine"},{"key":"10.1016\/j.pharmthera.2019.107428_bib1195","doi-asserted-by":"crossref","first-page":"1137","DOI":"10.1056\/NEJM198411013111801","article-title":"The effects of high-dose corticosteroids in patients with septic shock: A prospective, controlled study","volume":"311","author":"Sprung","year":"1984","journal-title":"The New England Journal of Medicine"},{"key":"10.1016\/j.pharmthera.2019.107428_bib1200","doi-asserted-by":"crossref","first-page":"1671","DOI":"10.1056\/NEJMoa051693","article-title":"NHLBI-ARDS Clinical Trials Network. Efficacy and safety of corticosteroids for persistent acute respiratory distress syndrome","volume":"354","author":"Steinberg","year":"2006","journal-title":"The New England Journal of Medicine"},{"key":"10.1016\/j.pharmthera.2019.107428_bib1205","first-page":"CD007720","article-title":"Corticosteroids for pneumonia","volume":"12","author":"Stern","year":"2017","journal-title":"The Cochrane Database of Systematic Reviews"},{"key":"10.1016\/j.pharmthera.2019.107428_bib1210","doi-asserted-by":"crossref","first-page":"2416","DOI":"10.1016\/S0140-6736(16)00578-X","article-title":"Acute respiratory distress syndrome","volume":"388","author":"Sweeney","year":"2016","journal-title":"Lancet"},{"key":"10.1016\/j.pharmthera.2019.107428_bib1215","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1183\/09031936.00081514","article-title":"Low-dose corticosteroid use and mortality in severe community-acquired pneumonia patients","volume":"45","author":"Tagami","year":"2015","journal-title":"The European Respiratory Journal"},{"key":"10.1016\/j.pharmthera.2019.107428_bib1220","doi-asserted-by":"crossref","first-page":"438","DOI":"10.47102\/annals-acadmedsg.V36N6p438","article-title":"Pharmacologic treatment of SARS: Current knowledge and recommendations","volume":"36","author":"Tai","year":"2007","journal-title":"Ann Acad Med Singapore"},{"key":"10.1016\/j.pharmthera.2019.107428_bib1225","doi-asserted-by":"crossref","first-page":"1594","DOI":"10.1097\/CCM.0b013e31819fb507","article-title":"Use of corticosteroids in acute lung injury and acute respiratory distress syndrome: A systematic review and meta-analysis","volume":"37","author":"Tang","year":"2009","journal-title":"Critical Care Medicine"},{"key":"10.1016\/j.pharmthera.2019.107428_bib1230","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1186\/cc6186","article-title":"Steroid treatment for persistent ARDS: A word of caution","volume":"11","author":"Thompson","year":"2007","journal-title":"Crit Care"},{"key":"10.1016\/j.pharmthera.2019.107428_bib1235","doi-asserted-by":"crossref","first-page":"1020","DOI":"10.1093\/infdis\/jix050","article-title":"Leukotriene A4 hydrolase genotype and HIV infection influence intracerebral inflammation and survival from tuberculous meningitis","volume":"215","author":"Thuong","year":"2017","journal-title":"The Journal of Infectious Diseases"},{"key":"10.1016\/j.pharmthera.2019.107428_bib1240","doi-asserted-by":"crossref","first-page":"1619","DOI":"10.1056\/NEJMoa1412278","article-title":"STOPAH Trial. Prednisolone or pentoxifylline for alcoholic hepatitis","volume":"372","author":"Thursz","year":"2015","journal-title":"The New England Journal of Medicine"},{"key":"10.1016\/j.pharmthera.2019.107428_bib1245","doi-asserted-by":"crossref","first-page":"1741","DOI":"10.1056\/NEJMoa040573","article-title":"Dexamethasone for the treatment of tuberculous meningitis in adolescents and adults","volume":"351","author":"Thwaites","year":"2004","journal-title":"The New England Journal of Medicine"},{"key":"10.1016\/j.pharmthera.2019.107428_bib1250","doi-asserted-by":"crossref","DOI":"10.1097\/SHK.0000000000001316","article-title":"Comparison between continuous and intermittent administration of hydrocortisone during septic shock: A randomized controlled clinical trial","author":"Tilouche","year":"2019","journal-title":"Shock"},{"key":"10.1016\/j.pharmthera.2019.107428_bib1255","doi-asserted-by":"crossref","first-page":"897","DOI":"10.1164\/rccm.200906-0937OC","article-title":"Targeting phosphoinositide-3-kinase-delta with theophylline reverses corticosteroid insensitivity in chronic obstructive pulmonary disease","volume":"182","author":"To","year":"2010","journal-title":"American Journal of Respiratory and Critical Care Medicine"},{"key":"10.1016\/j.pharmthera.2019.107428_bib1260","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1016\/j.cell.2011.12.023","article-title":"Host genotype-specific therapies can optimize the inflammatory response to mycobacterial infections","volume":"148","author":"Tobin","year":"2012","journal-title":"Cell"},{"key":"10.1016\/j.pharmthera.2019.107428_bib1265","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1016\/j.cell.2010.02.013","article-title":"The lta4h locus modulates susceptibility to mycobacterial infection in zebrafish and humans","volume":"140","author":"Tobin","year":"2010","journal-title":"Cell"},{"key":"10.1016\/j.pharmthera.2019.107428_bib1270","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1001\/jama.2015.88","article-title":"Effect of corticosteroids on treatment failure among hospitalized patients with severe community-acquired pneumonia and high inflammatory response: A randomized clinical trial","volume":"313","author":"Torres","year":"2015","journal-title":"JAMA"},{"key":"10.1016\/j.pharmthera.2019.107428_bib1275","doi-asserted-by":"crossref","first-page":"1359","DOI":"10.1056\/NEJMoa011300","article-title":"Intensive insulin therapy in critically ill patients","volume":"345","author":"van den Berghe","year":"2001","journal-title":"The New England Journal of Medicine"},{"key":"10.1016\/j.pharmthera.2019.107428_bib1280","doi-asserted-by":"crossref","first-page":"1029","DOI":"10.1093\/infdis\/jix051","article-title":"Clinical parameters, routine inflammatory markers, and LTA4H genotype as predictors of mortality among 608 patients with tuberculous meningitis in Indonesia","volume":"215","author":"van Laarhoven","year":"2017","journal-title":"The Journal of Infectious Diseases"},{"key":"10.1016\/j.pharmthera.2019.107428_bib1285","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1136\/thorax.58.5.383","article-title":"Dexamethasone for treatment of patients mechanically ventilated for lower respiratory tract infection caused by respiratory syncytial virus","volume":"58","author":"van Woensel","year":"2003","journal-title":"Thorax"},{"key":"10.1016\/j.pharmthera.2019.107428_bib1290","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1016\/S0009-9236(98)90066-2","article-title":"Plasma concentrations and effects of oral methylprednisolone are considerably increased by itraconazole","volume":"64","author":"Varis","year":"1998","journal-title":"Clinical Pharmacology and Therapeutics"},{"key":"10.1016\/j.pharmthera.2019.107428_bib1295","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1056\/NEJMoa1705835","article-title":"ADRENAL trial investigators and the australian\u2013New zealand intensive care society clinical trials group. Adjunctive glucocorticoid therapy in patients with septic shock","volume":"378","author":"Venkatesh","year":"2018","journal-title":"The New England Journal of Medicine"},{"key":"10.1016\/j.pharmthera.2019.107428_bib1300","doi-asserted-by":"crossref","first-page":"714","DOI":"10.1007\/s00134-007-0970-y","article-title":"Duration of adrenal inhibition following a single dose of etomidate in critically ill patients","volume":"34","author":"Vinclair","year":"2008","journal-title":"Intensive Care Medicine"},{"key":"10.1016\/j.pharmthera.2019.107428_bib1305","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1016\/S0140-6736(89)92574-9","article-title":"Diagnostic value of ascites adenosine deaminase in tuberculous peritonitis","volume":"1","author":"Voigt","year":"1989","journal-title":"Lancet"},{"key":"10.1016\/j.pharmthera.2019.107428_bib1310","doi-asserted-by":"crossref","first-page":"1220","DOI":"10.1007\/s00134-015-3899-6","article-title":"Glucocorticosteroids for sepsis: Systematic review with meta-analysis and trial sequential analysis","volume":"41","author":"Volbeda","year":"2015","journal-title":"Intensive Care Medicine"},{"key":"10.1016\/j.pharmthera.2019.107428_bib1315","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1677\/joe.0.1780037","article-title":"Corticosteroids, eosinophils and bronchial epithelial cells: New insights into the resolution of inflammation in asthma","volume":"178","author":"Walsh","year":"2003","journal-title":"The Journal of Endocrinology"},{"key":"10.1016\/j.pharmthera.2019.107428_bib1320","first-page":"CD001288","article-title":"Systemic corticosteroids for acute exacerbations of chronic obstructive pulmonary disease","volume":"9","author":"Walters","year":"2014","journal-title":"The Cochrane Database of Systematic Reviews"},{"key":"10.1016\/j.pharmthera.2019.107428_bib1325","doi-asserted-by":"crossref","first-page":"1248","DOI":"10.1164\/rccm.201207-1280OC","article-title":"Systemic steroid exposure is associated with differential methylation in chronic obstructive pulmonary disease","volume":"186","author":"Wan","year":"2012","journal-title":"American Journal of Respiratory and Critical Care Medicine"},{"key":"10.1016\/j.pharmthera.2019.107428_bib1330","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1378\/chest.15-1733","article-title":"Efficacy and safety of corticosteroids for community-acquired pneumonia: A systematic review and meta-analysis","volume":"149","author":"Wan","year":"2016","journal-title":"Chest"},{"key":"10.1016\/j.pharmthera.2019.107428_bib1335","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1016\/j.amjsurg.2012.11.018","article-title":"Corticosteroids and wound healing: Clinical considerations in the perioperative period","volume":"206","author":"Wang","year":"2013","journal-title":"American Journal of Surgery"},{"key":"10.1016\/j.pharmthera.2019.107428_bib1340","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1213\/ANE.0000000000000050","article-title":"Low-dose hydrocortisone therapy attenuates septic shock in adult patients but does not reduce 28-day mortality: A meta-analysis of randomized controlled trials","volume":"118","author":"Wang","year":"2014","journal-title":"Anesthesia and Analgesia"},{"key":"10.1016\/j.pharmthera.2019.107428_bib1345","doi-asserted-by":"crossref","first-page":"683","DOI":"10.3892\/etm.2015.2929","article-title":"Adjunctive corticosteroids for the treatment of Pneumocystis jiroveci pneumonia in patients with HIV: A meta-analysis","volume":"11","author":"Wang","year":"2016","journal-title":"Experimental and Therapeutic Medicine"},{"key":"10.1016\/j.pharmthera.2019.107428_bib1350","doi-asserted-by":"crossref","first-page":"13931","DOI":"10.1038\/srep13931","article-title":"Action mechanism of corticosteroids to aggravate Guillain-Barr\u00e9 syndrome","volume":"5","author":"Wang","year":"2015","journal-title":"Scientific Reports"},{"key":"10.1016\/j.pharmthera.2019.107428_bib1355","doi-asserted-by":"crossref","DOI":"10.1016\/j.chest.2019.06.017","article-title":"Corticosteroids for community-acquired pneumonia - overstated benefits and understated risks","author":"Waterer","year":"2019","journal-title":"Chest"},{"key":"10.1016\/j.pharmthera.2019.107428_bib1360","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1373\/jalm.2016.020206","article-title":"Prednisolone replacement therapy mimics the circadian rhythm more closely than other glucocorticoids","volume":"1","author":"Williams","year":"2016","journal-title":"J Applied Lab Med"},{"key":"10.1016\/j.pharmthera.2019.107428_bib1365","doi-asserted-by":"crossref","first-page":"1150","DOI":"10.1183\/13993003.00474-2016","article-title":"STEP Study Group. Pathogen- and antibiotic-specific effects of prednisone in community-acquired pneumonia","volume":"48","author":"Wirz","year":"2016","journal-title":"The European Respiratory Journal"},{"key":"10.1016\/j.pharmthera.2019.107428_bib1370","doi-asserted-by":"crossref","first-page":"e1000","DOI":"10.1097\/CCM.0000000000001833","article-title":"Combining prognostic and predictive enrichment strategies to identify children with septic shock responsive to corticosteroids","volume":"44","author":"Wong","year":"2016","journal-title":"Critical Care Medicine"},{"key":"10.1016\/j.pharmthera.2019.107428_bib1375","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1164\/rccm.201410-1864OC","article-title":"Developing a clinically feasible personalized medicine approach to pediatric septic shock","volume":"191","author":"Wong","year":"2015","journal-title":"American Journal of Respiratory and Critical Care Medicine"},{"key":"10.1016\/j.pharmthera.2019.107428_bib1380","first-page":"CD008148","article-title":"Corticosteroids for HELLP (hemolysis, elevated liver enzymes, low platelets) syndrome in pregnancy","volume":"9","author":"Woudstra","year":"2010","journal-title":"The Cochrane Database of Systematic Reviews"},{"key":"10.1016\/j.pharmthera.2019.107428_bib1385","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1016\/j.ajem.2017.07.050","article-title":"Efficacy of corticosteroid treatment for severe community-acquired pneumonia: A meta-analysis","volume":"36","author":"Wu","year":"2018","journal-title":"The American Journal of Emergency Medicine"},{"key":"10.1016\/j.pharmthera.2019.107428_bib1390","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1016\/j.jinf.2006.01.005","article-title":"Hong Kong Hospital Authority SARS Collaborative Group (HASCOG). Corticosteroid treatment of severe acute respiratory syndrome in Hong Kong","volume":"54","author":"Yam","year":"2007","journal-title":"The Journal of Infection"},{"key":"10.1016\/j.pharmthera.2019.107428_bib1395","doi-asserted-by":"crossref","first-page":"956","DOI":"10.1016\/j.cmi.2015.06.022","article-title":"Corticosteroids for the treatment of human infection with influenza virus: A systematic review and meta-analysis","volume":"21","author":"Yang","year":"2015","journal-title":"Clinical Microbiology and Infection"},{"key":"10.1016\/j.pharmthera.2019.107428_bib1400","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1016\/j.clinbiochem.2006.12.005","article-title":"Constrictive pericarditis: Detection of Mycobacterium tuberculosis in paraffin-embedded pericardial tissues by polymerase chain reaction","volume":"40","author":"Zamirian","year":"2007","journal-title":"Clinical Biochemistry"},{"key":"10.1016\/j.pharmthera.2019.107428_bib1405","doi-asserted-by":"crossref","first-page":"2517","DOI":"10.4049\/jimmunol.178.4.2517","article-title":"Glucocorticoid conditioning of myeloid progenitors enhances TLR4 signaling via negative regulation of the phosphatidylinositol 3-kinase-Akt pathway","volume":"178","author":"Zhang","year":"2007","journal-title":"Journal of Immunology"},{"key":"10.1016\/j.pharmthera.2019.107428_bib1410","article-title":"The effectiveness and safety of corticosteroids therapy in adult critical ill patients with septic shock: A meta-analysis of randomized controlled trials","author":"Zhu","year":"2018","journal-title":"Shock"}],"container-title":["Pharmacology & Therapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0163725819301809?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0163725819301809?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,27]],"date-time":"2025-09-27T22:07:19Z","timestamp":1759010839000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0163725819301809"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,2]]},"references-count":282,"alternative-id":["S0163725819301809"],"URL":"https:\/\/doi.org\/10.1016\/j.pharmthera.2019.107428","relation":{},"ISSN":["0163-7258"],"issn-type":[{"value":"0163-7258","type":"print"}],"subject":[],"published":{"date-parts":[[2020,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Use of glucocorticoids in the critical care setting: Science and clinical evidence","name":"articletitle","label":"Article Title"},{"value":"Pharmacology & Therapeutics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.pharmthera.2019.107428","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"107428"}}